Armistice Capital »

Blackberry shares owned by Armistice Capital

Quarter-by-quarter ownership of Blackberry (BB) shares owned by Armistice Capital from 13F filings

Historical chart of Armistice Capital investment in Blackberry

Tip: Access up to 7 years of quarterly data

All positions including Blackberry held by Armistice Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Blackberry by Armistice Capital

Quarter filed Position value Share count Share price at filing
2026-06-30 $199k 16k 12.65

More positions owned by Armistice Capital

State Str Spdr S&p 500 Etf T Tr Unit Put Option (SPY)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Cytokinetics Com New (CYTK)
Agios Pharmaceuticals (AGIO)
Madrigal Pharmaceuticals (MDGL)
Ptc Therapeutics I (PTCT)
Supernus Pharmaceuticals (SUPN)
Travere Therapeutics (TVTX)
Immunovant (IMVT)
Incyte Corporation (INCY)
Neurocrine Biosciences (NBIX)
UnitedHealth (UNH)
Mineralys Therapeutics (MLYS)
Freshpet (FRPT)
Dyne Therapeutics (DYN)

View all positions for Armistice Capital

Top funds holding Blackberry

Legal & General Group
Ing Investment Management
First Trust Advisors
Jane Street
Vanguard Capital Management
Citadel Advisors
D. E. Shaw & Co
Susquehanna International
Hood River Capital Management
Two Sigma Investments
Renaissance Technologies
Connor, Clark & Lunn Investment Management
Vanguard Fiduciary Trust
Bank of America Corporation
TD Asset Management

View all funds holding Blackberry